Home / Companies / CRISPR THERAPEUTICS AG / 30 May 2024
CRISPR THERAPEUTICS AG: meeting of 30 May 2024
Votes reported on Form N-PX, item by item
538 Form N-PX filers reported votes at the CRISPR THERAPEUTICS AG meeting of 30 May 2024. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
14 nominees; 70.6% of reported votes for; 74 filers withheld from or voted against at least one nominee.
2,036 vote records from 96 filers. 20 of the 90 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
804 vote records from 525 filers. 234 of the 480 filers that marked the item either way voted against management. 45 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. No share split is published for this item. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
162 vote records from 95 filers. 3 of the 89 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
372 vote records from 92 filers. 1 of the 86 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
1,448 vote records from 154 filers. 48 of the 145 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
780 vote records from 93 filers. 6 of the 87 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
144 vote records from 27 filers. 1 of the 25 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | Against * | Against * | For |
| Dimensional | Against * | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | Against * | Against * | For |
| Franklin Templeton | Against * | Against * | For |
| Invesco | For | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | No report | For | No report |
| ProShares and ProFunds | Against * | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | No report | Against * | No report |
| J.P. Morgan | For | For | For |
| Goldman Sachs | For | For | For |
| Jackson National funds | For | For | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | No report | Against * | No report |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | For | For |
| Voya | No report | Against * | No report |
| First Trust | Against * | Against * | For |
| Nationwide | For | For | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | Against * | Against * | For |
| BNY Mellon | No report | Against * | No report |
| Principal | No report | Against * | No report |
| Capital Group and American Funds | For | For | For |
| Global X | For | Against * | For |
| Transamerica | For | Against * | For |
| Federated Hermes | For | For | For |
| AllianceBernstein | No report | Against * | No report |
| PIMCO | Against * | Against * | Against * |
| Allspring | Against * | Against * | For |
| MassMutual | For | For | For |
| VanEck | For | Against * | For |
| Neuberger Berman | No report | Against * | No report |
| American Beacon | For | For | For |
| Natixis and Loomis Sayles | For | For | For |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the CRISPR THERAPEUTICS AG meeting?
538 Form N-PX filers reported votes at the meeting of 30 May 2024. On say-on-pay, 234 of 480 voted against management (48.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by CRISPR THERAPEUTICS AG on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for CRISPR THERAPEUTICS AG
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing CRISPR THERAPEUTICS AG with a meeting date within three days of 30 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.